Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Centice, a provider of drug verification and safety products, has successfully completed a $4 million bridge financing from its existing investors to support ongoing commercialization efforts for its innovative Pass Rx prescription verification product for the retail pharmacy marketplace.
Subscribe to our email newsletter
Leading the $4 million bridge financing were The Aurora Funds, and S-Group Direct Investments, along with participation from other existing investors Innovation Ventures and several individuals.
Ray Swanson, president and CEO of Centice, said: “We are very pleased to close on this round of new financing as these funds secure our ability to commercialize our Pass Rx product in 2009.”